[68Ga]ABY-025
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [68Ga]ABY-025, covering 2015-01-13 to 2015-01-13. Get the full timeline:
Most recent: Clinical Trial Update: PET Study of Breast Cancer Patients Using [68Ga]ABY-025 [Phase 1, Phase 2]